AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H2403-H2408, 2007. First published July 6, 2007; doi:10.1152/ajpheart.00288.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/H2403    most recent
00288.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, G.-X.
Right arrow Articles by Kimura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, G.-X.
Right arrow Articles by Kimura, S.

Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases

Guo-Xing Zhang,1 Yukiko Nagai,2 Toshitaka Nakagawa,2 Hiroshi Miyanaka,2 Yoshihide Fujisawa,2 Akira Nishiyama,1 Kunihiko Izuishi,3 Koji Ohmori,4 and Shoji Kimura1

1Department of Pharmacology, 2Life Science Research Center, 3Department of Gastroenterological Surgery, and 4Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University Medical School, Kagawa, Japan

Submitted 8 March 2007 ; accepted in final form 6 July 2007

Angiotensin II (ANG II) is a powerful activator of mitogen-activated protein (MAP) kinase cascades in cardiovascular tissues through a redox-sensitive mechanism. Nitric oxide (NO) is considered to antagonize the vasoconstrictive and proarteriosclerotic actions of ANG II. However, the role of endogenous NO in ANG II-induced redox-sensitive signal transduction is not yet clear. In this study using catheterized, conscious rats, we found that acute intravenous administration of NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg) enhanced phosphorylation of aortic MAP kinases extracellular signal regulated kinase (ERK) 1/2 and p38, which were suppressed only partially by a superoxide dismutase mimetic (Tempol), whereas ANG II-induced MAP kinase phosphorylation was markedly suppressed by Tempol. FK409, a NO donor, had little effect on vascular MAP kinase phosphorylation. On the other hand, acute exposure to a vasoconstrictor dose of ANG II (200 ng·kg–1·min–1 iv) failed to enhance phosphorylation of aortic MAP kinases in the chronically L-NAME-treated rats, whereas the vasoconstrictor effect of ANG II was not affected by L-NAME treatment. Furthermore, three different inhibitors of NO synthase suppressed, in a dose-dependent manner, ANG II-induced MAP kinase phosphorylation in rat vascular smooth muscle cells, which was closely linked to superoxide generation in cells. These results indicate the involvement of endogenous NO synthase in ANG II-induced signaling pathways, leading to activation of MAP kinase, and that NO may have dual effects on the vascular MAP kinase activation associated with redox sensitivity.

oxidative stress; NG-nitro-L-arginine methyl ester; extracellular signal-regulated kinase 1/2; p38



Address for reprint requests and other correspondence: S. Kimura, Dept. of Pharmacology, Kagawa Univ. Medical School, 1750-1 Ikenobe, Miki, Kagawa 761-0793, Japan (e-mail: kimura{at}kms.ac.jp)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G.-X. Zhang, S. Kimura, K. Murao, J. Shimizu, H. Matsuyoshi, and M. Takaki
Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation
Cardiovasc Res, February 1, 2009; 81(2): 389 - 399.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.